These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2783699)

  • 41. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind comparison of doxepin and desipramine in patients with primary affective disorder.
    Amsterdam JD; Caroff S; Potter L; Brunswick D; Conn JW; Rickels K
    Acta Psychiatr Scand; 1982 Apr; 65(4):292-300. PubMed ID: 7044045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
    Ansseau M; Ansoms C; Beckers G; Bogaerts M; Botte L; De Buck R; Diricq S; Dumortier A; Jansegers E; Owieczka J
    J Affect Disord; 1984 Dec; 7(3-4):287-96. PubMed ID: 6151958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative trial of trimipramine versus doxepin in depressed hospitalised patients.
    Assalian P; Rosengarten MD; Phillips R
    Drugs; 1989; 38 Suppl 1():32-4; discussion 49-50. PubMed ID: 2693053
    [No Abstract]   [Full Text] [Related]  

  • 46. [Changes in hemodynamic indicators during doxepin therapy as a prognostic factor in the treatment of endogenous depression].
    Magiera P; Smoczyński S; Jakitowicz J
    Psychiatr Pol; 1991; 25(3-4):44-50. PubMed ID: 1821977
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of fluoxetine in depression associated with multiple sclerosis.
    Shafey H
    Can J Psychiatry; 1992 Mar; 37(2):147-8. PubMed ID: 1562960
    [No Abstract]   [Full Text] [Related]  

  • 48. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
    McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
    Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clovoxamine and doxepin in major depressive disorder: a double-blind controlled trial.
    Lodge GJ; Freeman HL
    Br J Psychiatry; 1986 Jun; 148():718-21. PubMed ID: 3535975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
    Stratta P; Bolino F; Cupillari M; Casacchia M
    Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
    [No Abstract]   [Full Text] [Related]  

  • 51. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin.
    Luo H; Hawes EM; McKay G; Korchinski ED; Midha KK
    Drug Metab Dispos; 1991; 19(3):722-4. PubMed ID: 1680645
    [No Abstract]   [Full Text] [Related]  

  • 52. Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin.
    Brunswick DJ; Amsterdam JD; Potter L; Caroff S; Rickels K
    Acta Psychiatr Scand; 1983 Jun; 67(6):371-7. PubMed ID: 6880821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluoxetine at 20 mg per day: the recommended and therapeutic dose in the treatment of depression.
    Wernicke JF; Bosomworth JC; Ashbrook E
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():63-7. PubMed ID: 2644341
    [No Abstract]   [Full Text] [Related]  

  • 54. Criteria for use of fluoxetine hydrochloride in adult inpatients and outpatients.
    Savitsky PA
    Clin Pharm; 1990 Dec; 9(12):955-6. PubMed ID: 2292180
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of doxepin on blood pressure and heart rate in patients with primary major affective disorder.
    Linnoila M; Jobson KO; Gilliam JH; Paine RL
    J Clin Psychopharmacol; 1982 Dec; 2(6):433-4. PubMed ID: 7174869
    [No Abstract]   [Full Text] [Related]  

  • 56. Early onset of response to doxepin treatment.
    Barranco SF; Thrash ML; Hackett E; Frey J; Ward J; Norris E
    J Clin Psychiatry; 1979 Jun; 40(6):265-9. PubMed ID: 376498
    [No Abstract]   [Full Text] [Related]  

  • 57. Interaction of fluoxetine with carbamazepine.
    Pearson HJ
    J Clin Psychiatry; 1990 Mar; 51(3):126. PubMed ID: 2353956
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparison of manic switch onset during fluoxetine and trazodone treatment.
    Terao T
    Biol Psychiatry; 1993 Mar; 33(6):477-8. PubMed ID: 8490074
    [No Abstract]   [Full Text] [Related]  

  • 59. Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.
    Neshkes RE; Gerner R; Jarvik LF; Mintz J; Joseph J; Linde S; Aldrich J; Conolly ME; Rosen R; Hill M
    J Clin Psychopharmacol; 1985 Apr; 5(2):102-6. PubMed ID: 3988967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doxepin-induced cardiac dysrhythmia.
    Meador-Woodruff JH; Majchrzak MJ
    J Clin Psychopharmacol; 1988 Apr; 8(2):144-5. PubMed ID: 2453531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.